Sangamo Therapeutics Announces Fourth Quarter and Full Year 2025 Earnings Call

Click here to view

Careers
Clinical Trials
Contact

Science
Programs
Patients
Investors & Media
- Overview
- News Releases
- Events
- Presentations
- ESG
About

Science
Programs
Patients
Investors & Media
- Overview
- News Releases
- Events
- Presentations
- ESG
About

LinkedIn
Twitter

Presentation

Annual Pain Therapeutics Summit 2023

Zinc finger mediated epigenetic repression of SCN9A gene as a therapeutic approach for painful peripheral neuropathies

Download PDF

Sign up for email alerts

Company

Science
Programs
Collaborations
Patients
About
Careers
Contact

Latest

News Releases
Events
Science Presentations
Scientific Publications
Corporate Presentations

Resources

Pipeline
Clinical Trials
Legal Disclaimer
Privacy Policy

Social

LinkedIn
X

© 2026 Sangamo Therapeutics